Mylan, the drug company that created outrage with the dramatic price hike of the EpiPen, is on the defensive again. A new report shows a big rise in complaints about the device not working in life-threatening emergencies. Tony Dokoupil reports.
From: http://www.cbsnews.com/videos/mylan-on-defensive-again-after-complaints-of-reported-epipen-failures/
No comments:
Post a Comment